Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
Showing 1,281 - 1,300 results of 21,342 for search '(( significant ((shape decrease) OR (mean decrease)) ) OR ( significant decrease decrease ))', query time: 0.51s Refine Results
  1. 1281
    Summary of non-randomized studies.

    Summary of non-randomized studies. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1282
    PRISMA flow diagram of the systematic literature search process.

    PRISMA flow diagram of the systematic literature search process. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1283
    Newcastle-Ottawa scale.

    Newcastle-Ottawa scale. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1284
    Correlations between significantly different microbiota and metabolites.

    Correlations between significantly different microbiota and metabolites. by Bhuripit Saraphol (20855573)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1285
    (A-C) Force versus drill depth and torque versus drill depth.

    (A-C) Force versus drill depth and torque versus drill depth. by Marsel Ganeyev (21453399)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1286
    Changes in connectivity of the mPFC among responders and non-responders.

    Changes in connectivity of the mPFC among responders and non-responders. by Karel Joineau (21799908)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1287
    Data supporting this article.

    Data supporting this article. by Karel Joineau (21799908)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1288
    CONSORT diagram showing the flow of participants through each stage of the DOREPAR randomized trial for the main outcome (change of VAS).

    CONSORT diagram showing the flow of participants through each stage of the DOREPAR randomized trial for the main outcome (change of VAS). by Karel Joineau (21799908)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1289
    Demographic and clinical data at baseline.

    Demographic and clinical data at baseline. by Karel Joineau (21799908)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1290
    Changes in clinical variables.

    Changes in clinical variables. by Karel Joineau (21799908)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1291
    Change of functional connectivity in the SMN after intervention.

    Change of functional connectivity in the SMN after intervention. by Karel Joineau (21799908)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1292
    Connectivity between the left nucleus accumbens and two clusters.

    Connectivity between the left nucleus accumbens and two clusters. by Karel Joineau (21799908)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1293
    Design of the protocol.

    Design of the protocol. by Karel Joineau (21799908)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1294
    Schema of the reflexology circuit and the stimulated reflex zones. a.

    Schema of the reflexology circuit and the stimulated reflex zones. a. by Karel Joineau (21799908)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1295
    Viability of <i>L</i>. <i>intracellularis</i>.

    Viability of <i>L</i>. <i>intracellularis</i>. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 1296
    (A-B): Mean intraocular pressure (IOP) (A) and mean number of glaucoma medications (B) with standard deviations are shown for XEN (grey) and PRESERFLO (black) groups at baseline (preoperative), one day (1D), two weeks (2W), one month (1M) and 12, 24, and 36 months postoperatively.

    (A-B): Mean intraocular pressure (IOP) (A) and mean number of glaucoma medications (B) with standard deviations are shown for XEN (grey) and PRESERFLO (black) groups at baseline (p... by Cemre Altas (22537656)

    Published 2025
    Save to List
    Saved in:
  17. 1297
    Reduced cell viability in Dkp23- and Vaccine-infected PK-15 cells.

    Reduced cell viability in Dkp23- and Vaccine-infected PK-15 cells. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 1298
    Regulation of IL8 cytokine in <i>L</i>. <i>intracellularis</i> infected PK-15 cells.

    Regulation of IL8 cytokine in <i>L</i>. <i>intracellularis</i> infected PK-15 cells. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 1299
    Regulation of NF-κB target genes.

    Regulation of NF-κB target genes. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 1300
    Regulation of NF-κB target genes mRNA levels in <i>L</i>. <i>intracellularis</i> infected PK-15 cells.

    Regulation of NF-κB target genes mRNA levels in <i>L</i>. <i>intracellularis</i> infected PK-15 cells. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: